Anebulo Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Anebulo Pharmaceuticals (ANEB) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Anebulo Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Anebulo Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Anebulo Pharmaceuticals by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $42 | 25 | 1.68 |
2024-09-30 | $1.5k | 763 | 1.93 |
2024-03-31 | $413 | 144 | 2.87 |
2022-12-31 | $4.1k | 1.7k | 2.42 |
2022-09-30 | $8.0k | 2.8k | 2.88 |
2022-06-30 | $15k | 2.9k | 5.16 |
2022-03-31 | $15k | 2.2k | 6.96 |
2021-12-31 | $4.0k | 580 | 6.90 |
2021-09-30 | $6.0k | 848 | 7.08 |
2021-06-30 | $2.0k | 234 | 8.55 |